Inventor · disambiguated record
Tapan Sanghvi
Also filed as: SANGHVI TAPAN
4 granted patents·8 pending applications·6 citations·filing 2004–2022
66Inventor score
Top patents by PatentIndex Score
12 records- 0189US10815239B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Oct 27, 2020·3 cites·25 claims
- 0279US10160760B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted Dec 25, 2018·3 cites·63 claims
- 0368US11485739B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Nov 1, 2022·0 cites·18 claims
- 0460US2014235705A1Formulations of thiophene compoundsVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 0557US2022265765A1C3 fusion protein and methods of making and using thereofBIOAXONE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0654US2007043070A1Weak base saltsYALKOWSKY SAMUEL H·Filed 2004·Application pending·0 cites
- 0753US11324802B2C3 fusion protein and methods of making and using thereofBIOAXONE BIOSCIENCES INC·Filed 2018·Granted May 10, 2022·0 cites·9 claims
- 0852US2018318301A1Formulations of azaindole compoundsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 0952US2021008072A1Formulations of azaindole compoundsVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 1049US2015065439A1Pharmaceutical compositionsVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 1147US2013195797A1High potency formulations of vx-950VERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1245US2016250213A1Formulations of azaindole compoundsVERTEX PHARMA·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →